Russia seeks collaboration with India for manufacturing Covid vaccine Sputnik V: Report

Sputnik V has been developed by the Gamaleya Research Institute of Epidemiology and Microbiology along with Russian Direct Investment Fund (RDIF). The vaccine has not been tested in phase 3 or larger clinical trials. There has been scepticism in some quarters about limited data related to the efficacy of the vaccine.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news